# RESOLUTE ONYX Post-Approval Study

> **NCT03063749** · — · COMPLETED · sponsor: **Medtronic Vascular** · enrollment: 416 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
- **DEVICE:** Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System

## Key facts

- **NCT ID:** NCT03063749
- **Lead sponsor:** Medtronic Vascular
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-30
- **Primary completion:** 2018-10-20
- **Final completion:** 2022-08-18
- **Target enrollment:** 416 (ACTUAL)
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03063749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03063749, "RESOLUTE ONYX Post-Approval Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03063749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*